Itron (NASDAQ:ITRI) Upgraded to Hold at Zacks Research

Zacks Research upgraded shares of Itron (NASDAQ:ITRI) from a strong sell rating to a hold rating in a report issued on Wednesday morning,Zacks.com reports.

Several other brokerages also recently issued reports on ITRI. JPMorgan Chase & Co. reduced their price objective on Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a research report on Thursday, April 16th. Oppenheimer upped their target price on shares of Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a report on Thursday, April 16th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Itron in a research note on Friday, May 8th. Raymond James Financial started coverage on shares of Itron in a research report on Tuesday, April 21st. They issued an “underperform” rating for the company. Finally, TD Cowen reduced their price objective on shares of Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Eight equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $131.33.

Itron Trading Down 3.4%

Shares of ITRI opened at $98.85 on Wednesday. The company has a debt-to-equity ratio of 0.96, a current ratio of 2.75 and a quick ratio of 2.24. The firm has a 50 day simple moving average of $84.38 and a 200-day simple moving average of $89.82. Itron has a 1-year low of $77.77 and a 1-year high of $142.00. The stock has a market cap of $4.33 billion, a price-to-earnings ratio of 16.50, a price-to-earnings-growth ratio of 0.84 and a beta of 1.32.

Itron (NASDAQ:ITRI) last posted its earnings results on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.29 by $0.30. The firm had revenue of $562.90 million for the quarter, compared to analyst estimates of $566.34 million. Itron had a return on equity of 19.26% and a net margin of 11.90%.Itron’s revenue was down 7.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.62 EPS. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. Equities analysts forecast that Itron will post 6.45 EPS for the current fiscal year.

Insider Buying and Selling at Itron

In other Itron news, SVP John F. Marcolini sold 322 shares of Itron stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total value of $27,167.14. Following the completion of the sale, the senior vice president owned 24,689 shares in the company, valued at $2,083,010.93. The trade was a 1.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald L. Reeves III sold 319 shares of the stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total transaction of $26,914.03. Following the transaction, the senior vice president owned 29,100 shares in the company, valued at approximately $2,455,167. The trade was a 1.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 3,946 shares of company stock worth $324,420 in the last 90 days. 1.77% of the stock is owned by company insiders.

Hedge Funds Weigh In On Itron

Several institutional investors and hedge funds have recently bought and sold shares of ITRI. Private Trust Co. NA boosted its holdings in shares of Itron by 112.4% in the 4th quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock valued at $25,000 after purchasing an additional 145 shares during the last quarter. Employees Retirement System of Texas acquired a new stake in shares of Itron during the 3rd quarter worth $32,000. Northwestern Mutual Wealth Management Co. raised its position in shares of Itron by 29.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock worth $41,000 after buying an additional 101 shares during the period. Advisory Services Network LLC purchased a new position in shares of Itron in the 3rd quarter worth $49,000. Finally, EverSource Wealth Advisors LLC boosted its holdings in Itron by 25.3% in the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after acquiring an additional 81 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Key Stories Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Itron reported second-quarter adjusted earnings of $1.59 per share, well above the $1.29 analyst consensus. Strong margins, demand for its services and a solid backlog helped offset revenue of $562.9 million, which fell short of expectations. ITRI Q2 Earnings Top Despite Soft Revenues, Solid View Lifts Stock 26%
• Positive Sentiment: Management raised its fiscal 2026 earnings outlook to $6.30-$6.50 per share and projected third-quarter EPS of $1.50-$1.60. Investors viewed the improved profit outlook and margin performance as more important than the revenue shortfall, triggering a sharp post-earnings rally. Itron jumps after profit beat and upbeat outlook
• Positive Sentiment: Needham raised its price target from $116 to $128 and maintained a Buy rating, implying substantial potential upside from recent trading levels. The average analyst target indicates approximately 25% upside, although price-target estimates are not always reliable. Itron Raises Profit Outlook While Revenue Growth Remains Uneven
• Neutral Sentiment: Zacks highlighted Itron’s valuation, growth and momentum characteristics, while noting that analyst estimate revisions are a more useful signal than the consensus price target alone. Are Investors Undervaluing Itron Right Now?
• Negative Sentiment: Revenue declined 7.2% year over year, and the quarterly sales miss plus an initially softer third-quarter sales outlook raise concerns about uneven top-line growth. The recent pullback also appears consistent with profit-taking after the stock’s large post-earnings advance. Itron Missed Revenue and Still Jumped 26%

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.